Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cidara Therapeutics, Inc. | Vice President, Finance | Common Stock | 59.4K | $56.3K | $0.95 | Mar 31, 2022 | Direct |
Cidara Therapeutics, Inc. | Vice President, Finance | Employee Stock Option (right to buy) | 20K | Mar 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CDTX | Cidara Therapeutics, Inc. | Mar 31, 2022 | 2 | $0 | 4 | Apr 4, 2022 | Vice President, Finance |
CDTX | Cidara Therapeutics, Inc. | Mar 21, 2022 | 1 | -$530 | 4 | Mar 23, 2022 | Vice President, Finance |
CDTX | Cidara Therapeutics, Inc. | Mar 11, 2022 | 1 | -$671 | 4 | Mar 11, 2022 | Vice President, Finance |
CDTX | Cidara Therapeutics, Inc. | Dec 29, 2021 | 3 | -$520 | 4 | Jan 7, 2022 | Vice President, Finance |
CDTX | Cidara Therapeutics, Inc. | Sep 30, 2021 | 1 | $0 | 4/A | Oct 5, 2021 | Vice President, Finance |
CDTX | Cidara Therapeutics, Inc. | Jul 30, 2021 | 1 | $0 | 4 | Jul 30, 2021 | Vice President, Finance |
CDTX | Cidara Therapeutics, Inc. | Jul 9, 2021 | 0 | $0 | 3 | Jul 19, 2021 | Vice President, Finance |